Literature DB >> 3882482

Developmental acquisition of type X collagen in the embryonic chick tibiotarsus.

T M Schmid, T F Linsenmayer.   

Abstract

The temporal and spatial distribution of short chain skeletal (Type X) collagen was immunohistochemically examined in the chick tibiotarsus from 6 days of embryonic development to 1 day posthatching. The monoclonal antibody employed (AC9) was recently produced and characterized as being specific for an epitope located within the helical domain of the type X collagen molecule (T. M. Schmid and T. F. Linsenmayer, J. Cell Biol., in press). The earliest detectable appearance of type X collagen was at 7.5 days, at which time it was restricted to a middiaphyseal location (i.e., in the primary center of ossification). This was in marked contrast to type II collagen, which appears earlier and is distributed throughout the cartilaginous anlagen. With increasing embryonic age, the reactivity with the type X antibody progressively extended toward the epiphyses, lagging somewhat behind the progression of chondrocyte hypertrophy. The anti-type X collagen antibody also reacted with the bony matrix itself, but the immunofluorescent signal produced by this source was considerably less than that produced by cartilage. At 19 days of development, a new small site of type X deposition was initiated in an epiphyseal location, which subsequently enlarged in circumference. These results are consistent with our previous biochemical studies suggesting that, in cartilage, type X collagen is specifically a product of that population of chondrocytes which have undergone hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882482     DOI: 10.1016/0012-1606(85)90319-7

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  41 in total

1.  Partial characterization of cell-type X collagen interactions.

Authors:  Steven P Luckman; Elaine Rees; Alvin P L Kwan
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

2.  The distribution of Notch receptors and their ligands during articular cartilage development.

Authors:  A J Hayes; G P Dowthwaite; S V Webster; C W Archer
Journal:  J Anat       Date:  2003-06       Impact factor: 2.610

3.  Localization of collagen X in human fetal and juvenile articular cartilage and bone.

Authors:  A G Nerlich; T Kirsch; I Wiest; P Betz; K von der Mark
Journal:  Histochemistry       Date:  1992-12

4.  Expression of type X collagen is transiently stimulated in redifferentiating chondrocytes pretreated with retinoic acid.

Authors:  M Sanchez; E Gionti; G Pontarelli; A Arcella; F De Lorenzo
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

5.  Modulation of endochondral development of the distal femoral condyle by mechanical loading.

Authors:  Sona Sundaramurthy; Jeremy J Mao
Journal:  J Orthop Res       Date:  2006-02       Impact factor: 3.494

6.  Isolation of bovine type X collagen and immunolocalization in growth-plate cartilage.

Authors:  T Kirsch; K von der Mark
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

7.  Coordinate inhibition of alkaline phosphatase and type X collagen syntheses by 1,25-dihydroxyvitamin D3 in primary cultured hypertrophic chondrocytes.

Authors:  S Inao; H E Conrad
Journal:  Calcif Tissue Int       Date:  1992-05       Impact factor: 4.333

8.  Partial characterization of the C-terminal non-collagenous domain (NC1) of collagen type X.

Authors:  R E Barber; A P Kwan
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

9.  Electron microscopic study of chondroid tissue in the cat mandible.

Authors:  M Goret-Nicaise; A Dhem
Journal:  Calcif Tissue Int       Date:  1987-04       Impact factor: 4.333

10.  Changes in osteonectin distribution and levels are associated with mineralization of the chicken tibial growth cartilage.

Authors:  M Pacifici; O Oshima; L W Fisher; M F Young; I M Shapiro; P S Leboy
Journal:  Calcif Tissue Int       Date:  1990-07       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.